Italia markets open in 6 hours 20 minutes

AVIR240621P00002500

. Valuta in USD.
Aggiungi a watchlist
- (-)
Schermo intero
Chiusura precedenteN/D
ApertoN/D
DenaroN/D
DomandaN/D
Prezzo d'esercizioN/D
ScadenzaN/D
Min-Max giornoN/D - N/D
Contratto - Min-MaxN/D
VolumeN/D
Open InterestN/D
  • GlobeNewswire

    Atea Pharmaceuticals to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that members of the Atea management team will participate in a fireside chat and present a business update at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023 at 10:10 a.m. ET. A live webcast of the pre

  • GlobeNewswire

    Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

    Enrollment continues in global Phase 3 SUNRISE-3 trial evaluating bemnifosbuvir for treatment of COVID-19Phase 3 SUNRISE-3 trial protocol amended to broaden eligibility criteria for high-risk patients and adapt to current COVID-19 environmentEnrollment continues in Phase 2 trial evaluating combination of bemnifosbuvir and ruzasvir for treatment of hepatitis C (HCV) with initial results expected in 4Q23Conference call at 4:30 pm ET today BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceutic

  • GlobeNewswire

    Atea Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023

    BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Tuesday, August 8, 2023, at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2023, and to provide a business update. To access the live conference call, pa